Exhibiting at VIV Asia 2025

NewBorn Animal Care SAS, headquartered in Lamballe-Armor, France, is an innovative manufacturer of nutraceutical solutions for both livestock and companion animals. With a strong commitment to animal health and welfare, the company combines veterinary science, palatability technology, and functional nutrition to create effective, user-friendly products that support animals from birth through all life stages. Positioned at the intersection of animal nutrition and pharmaceutical-grade supplementation, NewBorn Animal Care (NAC) serves veterinarians, integrators, and pet care professionals across Europe and international markets.

Core Business and Product Portfolio

NAC operates through two primary verticals:

• Livestock Nutraceuticals:

  • Raizup® – A functional feed additive designed to stimulate early gut development and immune resilience in newborn piglets and calves. It promotes rapid gastrointestinal adaptation and reduces mortality associated with early-life stress.

• Companion Animal Nutraceuticals:

  • EasyPill® – A patented palatable vector system that facilitates voluntary oral administration of medicines and supplements for dogs and cats.
  • MyPet® – A line of pet health supplements formulated for joint support, digestive care, and stress management.

These product lines are tailored to meet specific health goals, including improved feed intake, immunity, digestion, mobility, and compliance in medication delivery.

Specialization and Unique Selling Proposition (USP)

NewBorn Animal Care’s unique value proposition lies in its proprietary vector and palatability technologies developed specifically for animals. The EasyPill technology, for instance, ensures:

• Voluntary ingestion of tablets or supplements by masking unpleasant tastes
• High product acceptance rates in dogs and cats (>95% voluntary intake in trials)
• Flexible formulation for both prescription and non-prescription supplements

Raizup, on the other hand, is uniquely positioned in the early-life segment of livestock farming, where it addresses neonatal gut health, FCR improvement, and weaning performance—a niche but critical phase in livestock productivity.

Certifications and Quality Compliance

All products from NAC are manufactured under stringent European quality and safety standards. Key compliance and certifications include:

• GMP (Good Manufacturing Practices)
• ISO 22000 for food safety management systems
• Compliance with European Feed Additive Register for nutraceuticals
• Rigorous palatability and efficacy trials conducted under veterinary supervision

Each product batch is subject to full traceability and quality assurance to ensure consistent safety, bioavailability, and effectiveness.

Export and Shipment Records

NewBorn Animal Care has grown its international presence through a network of distributors and veterinary partners. Based on trade activity and company disclosures:

• NAC exports to over 30 countries including Germany, Spain, Italy, Canada, and South Korea
• Products like EasyPill have become market leaders in Europe for companion animal oral compliance
• Raizup is gaining traction in emerging markets focused on antibiotic-free livestock production
• Estimated international shipment volume exceeds 150,000+ units annually

Their robust logistics and compliance systems have enabled smooth cross-border operations, especially in regions with strict veterinary product regulations.

Financial and Operational Capabilities

As a growing SME in the European veterinary health sector, NAC has built a lean but technically strong operational model:

• In-house R&D team comprising veterinarians, pharmacologists, and food technologists
• Specialized production units with controlled environments for nutraceutical manufacturing
• Estimated annual turnover ranges between EUR 10–15 million, supported by both domestic and export growth
• Strategic investment in product innovation, user compliance, and animal welfare outcomes

These strengths support NAC’s ambition to be a reference brand in both the veterinary and pet health segments.

Target Market and Industry Positioning

NAC’s customer base spans:

• Veterinary clinics and hospitals
• Livestock integrators and commercial farms
• Pet retail and pharmacy chains
• B2B partners for private-label nutraceutical solutions

With growing demand for non-pharmaceutical interventions, antibiotic-free animal production, and compliance-boosting solutions in pets, NAC is uniquely positioned to lead these niche but expanding segments.

Recognitions and Industry Engagement

NewBorn Animal Care is actively engaged in industry platforms and scientific communities, including:

• Regular participation in EuroTier, VIV Europe, and VetForum events
• Peer-reviewed product research published in veterinary journals
• Collaborations with French National Veterinary Schools for clinical trials and palatability studies

The company has also been featured in European pet health magazines and livestock innovation forums for its leadership in palatability enhancement and neonatal livestock health.

NewBorn Animal Care SAS continues to drive innovation in the veterinary nutraceutical space by blending functionality, compliance, and science—ensuring better health outcomes for both farm animals and pets in a sustainable, user-friendly manner.